A blog exploring pharmaceutical relationship marketing, emarketing and innovation with a focus on rare disorders.
SirenWired
The convergence of rare disease, digital communications, and pharmaceutical marketing communications

#SocPharm Tweetchat Transcript 1/6/2010

Posted by | 4:28pm on Wednesday, January 6, 2010

:
Welcome to social media & pharma. Let’s start w/ introductions. Plse say who you are & why you are interested in sm & pharma. #socpharm 1/6/2010 20:01

:
I’ll start, I work for a digital agency that focuses on pharma. I’m fascinated by sm & how it can be used 2 help pts/drs #SocPharm 1/6/2010 20:02

:
I’m Heather Powell, compliance/regulatory atty at Daiichi Sankyo. Want to help co. use SM effectively and compliantly. #socpharm #SocPharm 1/6/2010 20:02

:
@ Dana Webster – SM Specialist for ParaPRO pharma. In industry 10 yrs mostly in Diabetes sales #socpharm 1/6/2010 20:03

:
#socpharm – hello Eileen! Fabio Gratton here from Ignite Health. SM & Pharma is in my blood. Not interested. Just need it to live. :) 1/6/2010 20:03

:
Blausen Group, creator of 3D medical animation library for web & mobile- interested in patient & medical education worldwide #socpharm 1/6/2010 20:04

:
Work for @ on behalf of our Pharma clients, interested in seeing community thoughts around SM/FDA/Pharma #socpharm 1/6/2010 20:04

:
@ I’m Frieda Hernandez of Siren Interactive & cnosider that I’m part of the community #socpharm 1/6/2010 20:04

:
@ I don’t know the answer to that. I’ve only used Tweetchat.com but @ recommended twebevent. #socpharm 1/6/2010 20:04

:
@ http://tweetchat.com/room/socpharm is a good interface for hashtag chats #socpharm 1/6/2010 20:05

:
Tom Stitt, principal @, open source apps for healthcare, sometimes I moderate the #hcmktg chat, curious about #socpharm 1/6/2010 20:05

:
@ looks like twebevent is a html wrapper around tweetchat anyway #socpharm 1/6/2010 20:05

:
Kathy Mackey, Niche Marketer, watching trends in medical, pharma, & technology #SocPharm 1/6/2010 20:06

:
Tx for organizing Eileen!Chris Iafolla from SHIFT Communications. Intrigued by potential & challenges of SM for pharma #SocPharm #SocPharm 1/6/2010 20:06

:
Media Specialist @, working primarily with pharma clients. Trying to learn as much as I can. #socpharm 1/6/2010 20:07

:
I’m Maureen Miller from @, interested to see how SM bridges PR & interactive marketing. #SocPharm 1/6/2010 20:08

:
Updated www.fdasm.com so the #socpharm stream also appears now (in case you’re interested). Avail on mobile: http://m.fdasm.com/tweets.html 1/6/2010 20:09

:
Hello Eileen! Angela Dunn here. #socpharm 1/6/2010 20:09

:
Thanks for virtually coming together everyone! #socpharm 1/6/2010 20:10

:
hi all–tough day today but i’m joining the conversation for some interesting conversation and ideas tonight! #SocPharm 1/6/2010 20:10

:
I’m Erica Friedman, information professional in pharma for almost 25 years. I’d like pharma to talk to people instead of at them. #socpharm 1/6/2010 20:11

:
Don’t know if @ can make it tonight, but he’s supporting us via http://socialpharmer.com where we’ll post transcripts. #socpharm 1/6/2010 20:11

:
@ Very cool, Fabio #socpharm 1/6/2010 20:11

:
And if anybody can aggregate data well, it’s @ #socpharm 1/6/2010 20:11

:
Topic 1: What’s your biggest social media project for 2010? What aspect of social media will you be focusing on this year? #socpharm 1/6/2010 20:11

:
Update: www.fdasm.com now updated to feature #socpharm stream. Also avail on mobile devices m.fdasm.com. Follow now to hear the SM convo. 1/6/2010 20:13

:
@ I think that’s the *biggest* challenge I’ve encountered. Most marketers want to vomit value on people. #socpharm 1/6/2010 20:13

:
Nice! RT @: I’m Erica Friedman, infoprof in pharma 4 almost 25 years. I’d lk pharma 2 talk 2 ppl instead of at them. #socpharm 1/6/2010 20:14

:
@ is @ developing a #SM POV? Interested what pharma co’s are putting stake in the ground pre-FDA guidance #socpharm 1/6/2010 20:15

:
Biggest challenge? Awaiting #FDASM guidance and hoping not to mess anything up in the process #SocPharm 1/6/2010 20:15

:
@ : Creating an environment 4 mktrs 2 learn 2 curate & converse rather than broadcast is STILL a key objective 4 me #socpharm 1/6/2010 20:15

:
Biggest 2010 SM Project: Get clients 2 move forward w/SM despite anticipation & unlikely issuance of Internet/SM policies til ’11 #socpharm 1/6/2010 20:16

:
@ So we’re still in education mode w/key pharma stakeholders? #socpharm 1/6/2010 20:17

:
I am Jack healthcare digital agency strategy type guy who is still hard at work & thus will be lurking #socpharm 1/6/2010 20:17

:
Biggest challenge is developing framework and guidelines and setting appropriate expectations w/brand teams. #SocPharm 1/6/2010 20:17

:
@ @ this is hardly unique to pharma… lots of verticals dont engage with consumers and dont get why they shld #socpharm 1/6/2010 20:18

:
@ I think we started in evangelism mode and are just now moving into education mode with key stakeholders. #SocPharm 1/6/2010 20:18

:
We are exanding our medical mobile apps internationally & generating patient & medical education opportunities via social media #SocPharm 1/6/2010 20:18

:
@ : I’m hearing anecdotes and seeing behaviour that leads me to believe that corps are outsourcing the skillset #socpharm 1/6/2010 20:18

:
2010 SM Project: Harness/amplify patient voice.They are key 2 everything we do. If we are not patients today, we will be tomorrow #socpharm 1/6/2010 20:19

:
Meredith Gould, zipping in somewhat late but here nevertheless. Sociologist, online strategy content development and curation. #socpharm 1/6/2010 20:19

:
we like squeaky wheels! :-) RT @: @ : I don’t get paid to do SM… I’m just a really loud, squeaky wheel. #socpharm 1/6/2010 20:19

:
Biggest SM project: educating clients and colleagues on social media, how/why to use it before they try 2 reach customers with it #socpharm 1/6/2010 20:20

:
@ True, all industries face challenges with SM, but pharma has a particularly tough row to hoe. #SocPharm 1/6/2010 20:20

:
Biggest challenge: balancing act between regulatory and actually adding value. #socpharm 1/6/2010 20:21

:
Which skills sets are we referring to (re: outsourcing)? #socpharm 1/6/2010 20:21

:
@ I think that is a concept lost on many pharma marketers. In addition to ROI, we should be talking ROH, Return on Health #SocPharm 1/6/2010 20:21

:
RT @: 2010 SM Project: Harness/amplify patient voice.They are key 2 everything we do. (True for all healthcare) #SocPharm 1/6/2010 20:21

:
@ every vertical has its unique challenges. finance has similar hurdles to pharma, for example. #socpharm 1/6/2010 20:21

:
@ : tru. but the concept of engagement just seems SO foreign 2 my marketing colleagues. like they dont grok it at ALL #socpharm 1/6/2010 20:22

:
@ definitely seeing that many co’s are outsourcing SM. Doesn’t that defy SM it by definition? Transparency, etc. #SocPharm 1/6/2010 20:23

:
@ the megaphone has been the default for years. still foreign to listen for many. #socpharm 1/6/2010 20:23

:
@ I agree there is a disconnect at times. SM is not one-way communications. #SocPharm 1/6/2010 20:23

:
@ Very true. Finance and pharma are similar in reg environment. Some don’t face that such as B2B tech for example! #SocPharm 1/6/2010 20:23

:
@ we do SM for some of our consumer clients. we’re very upfront about that fact tho. its all in how youdo it. #socpharm 1/6/2010 20:24

:
@ : and both being regulated leads to that IMHO. It feels some days, tho, that mktg doesn’t know how to talk with ppl #socpharm 1/6/2010 20:24

:
big issue : lack of desire for pharma mkters to spend the time ‘learning’ and experimenting with SM -hence need 2 outsource #socpharm 1/6/2010 20:25

:
Need 2 tape that message on our monitors, carve it on bberry, make screensaver 4 iphones, & staple 2 our head. It’s ALL abt HEALTH #socpharm 1/6/2010 20:25

:
@ Good point, change takes time. The old way of marketing/PR has been around for many years. #socpharm 1/6/2010 20:25

:
@ I don’t think it does. Pharma ultimately interacts but needs guidance, strategy, monitoring, etc…all outsourced . #SocPharm 1/6/2010 20:25

:
@ or that they think that ‘consumers’ arent ‘people’ #socpharm 1/6/2010 20:25

:
@ I think that’s great! They chose to bring someone (me) inhouse here to avoid a perceived conflict #SocPharm 1/6/2010 20:26

:
When I worked for a hospital we tracked all of our jobs via “the pathway to the patient”. How what u did impacted patients. #socpharm 1/6/2010 20:26

:
@ : I’m seeing that the skillset of “understanding what Social Media/ Networking is” is being outsourced. #socpharm 1/6/2010 20:26

:
Hi everyone! SM project for 2010: Social Media 360 monitoring, to better path the way to SM education to colleagues/stakeholders #socpharm 1/6/2010 20:26

:
@ I do agree with you in the pharma industry. My comment was intended more generally (my apologies 4 not clarifying) #SocPharm 1/6/2010 20:26

:
Technology is driving change fastr than companies can adapt 2 new expectations/behavior. Something’s got to give. #socpharm 1/6/2010 20:27

:
@ : ROI still grates on me. How does knowing that 100,000 of my ads are never seen except by bird poop a good ROI #socpharm 1/6/2010 20:27

:
Might be helpful to know that pharma isn’t the only healthcare group that has to learn a new way of communicating to users #SocPharm 1/6/2010 20:27

:
@ Don’t pharma marketers outsource everything else? #socpharm 1/6/2010 20:27

:
Outsourcing what skill sets? Strategy/creative? What companies? Agencies or pharma companies? #socpharm 1/6/2010 20:27

:
According 2 @: y is that every company thinks they have 2 have 2 talk about themselves when it comes 2 social media. #socpharm 1/6/2010 20:28

:
@ No worries! I think it is fine line to walk. Advise, counsel, monitor, are all okay. Misrepresenting is not! #SocPharm 1/6/2010 20:28

:
@ not by a long shot. #socpharm 1/6/2010 20:28

:
Glad that @ is taking part since he pointed me to the AZ AE tweet. #socpharm 1/6/2010 20:28

:
RT @ ROI grates on me. How does knowing that 100,000 of my ads are never seen except by bird poop a good ROI #socpharm /YES! 1/6/2010 20:29

:
Sorry. Knowing that I can pinpoint my target demo using Social Networking so precisely still feels like it trumps most ROI calcs. #socpharm 1/6/2010 20:29

:
@ I’m with you on ROI. Among many things, it’s a lagging indicator. #SocPharm 1/6/2010 20:29

:
T1 Biggest social media project: obliterating jargon and enhancing health literacy. #socpharm 1/6/2010 20:29

:
This is why I usually don’t get invited back to places like this… I talk too much #socpharm 1/6/2010 20:29

:
The problem with ROI is that the R has meant $ and now it means engagement leading to $. #socpharm 1/6/2010 20:30

:
Agreed RT @: Technology is driving change fastr than companies cn adapt 2 new expectations/behavior. Something’s got 2 giv. #socpharm 1/6/2010 20:30

:
yes pharma tends to outsource 2much! But SM seems even > RT @: @ Don’t pharma marketers outsource everything? #socpharm 1/6/2010 20:30

:
ROI is a marketing term, and until we move away from SM as marketing we are stuck with it. SM is relationship building. #SocPharm 1/6/2010 20:30

:
Scott Adams just wrote a great post about how humans value things we can measure over things that we can’t. #socpharm 1/6/2010 20:32

:
It still gets me we’re looking for ROI when the $ investment is … well, practically ZERO: http://tweetphoto.com/8168872 #socpharm 1/6/2010 20:32

:
personally believe our collective challenge is improving public perception about patients (not $) being top priority of pharma #SocPharm 1/6/2010 20:32

:
When people bring up ROI I just say, “easy numbers are easy, but they don’t necessarily have any value.” #socpharm 1/6/2010 20:32

:
@ : and you can’t buy a “relationship list” you’ve gotta work at it. #socpharm 1/6/2010 20:33

:
RT @: ROI is a marketing term, until we move away frm SM as marketing we r stuck with it. SM is relationship bldng. #SocPharm 1/6/2010 20:33

:
interesting disc. on ROI. On the sales side, EVERYTHING is about ROI and hitting numbers #SocPharm 1/6/2010 20:33

:
Topic 2: Look at account http://twitter.com/AZhelps for Nezium. What do u think of this? See AE tweet, does it violate privacy? #socpharm 1/6/2010 20:33

:
not sure ROI is a mktg term but a Finance one! Never heard a marketer raise it wout finance breathing downneck! RT @: #SocPharm 1/6/2010 20:33

:
@ Patient relationships still a new competency in pharma no matter what media #SocPharm 1/6/2010 20:34

:
We are so numbers focused at the beginning, but in the end we want to see HUMAN results: http://tweetphoto.com/8168952 #socpharm 1/6/2010 20:34

:
@ will defer comment on AZ as they employ my husband and pay the majority of my medical insurance #SocPharm 1/6/2010 20:34

:
I’m having fun explaining to mktrs I work with I’ve built a good following on my Twitter accounts and PodCast. Only taken 5 years #socpharm 1/6/2010 20:35

:
@ No worries! I also should’ve said that we’ll consider the comments tonight personal views and not reflecting employers. #socpharm 1/6/2010 20:36

:
! RT @: personally blv R collective challenge is improving public perception abt pts (not $) being top priority of pharma #SocPharm 1/6/2010 20:36

:
@ @ Pharma constraint itself by only looking at marketing aspects #socpharm 1/6/2010 20:37

:
RT @: I’m having fun explaining to mktrs I’ve built a good following on my Twitter and PodCast. Only taken 5 years #socpharm 1/6/2010 20:37

:
Pharma has not known the patient – they never needed to – that was not their “customer” – but things have changed. #socpharm 1/6/2010 20:38

:
Great point. RT @: @ Patient relationships still a new competency in pharma no matter what media #socpharm #socpharm 1/6/2010 20:38

:
@: re roi and new treatment. I hope roi will be before that! #socpharm 1/6/2010 20:39

:
@ Good point. Patient now plays a larger role than ever in their own health and has more information. #SocPharm 1/6/2010 20:39

:
@ do you have a link? #socpharm 1/6/2010 20:40

:
@ me too! but who knows… #socpharm 1/6/2010 20:41

:
.. and MD plays a smaller role (sadly). With pharma having a lot to lose, they need to step up. It’s not really an option. #socpharm 1/6/2010 20:41

:
Absoluyely! RT @ Patient relationships still a new competency in pharma no matter what media #SocPharm 1/6/2010 20:42

:
@ it would be great if it were just a public perception… #SocPharm 1/6/2010 20:43

:
So, no one wants to talk about http://twitter.com/AZhelps? #socpharm 1/6/2010 20:43

:
@ here’s the link http://bit.ly/8dmhBM (not sure if it is available if not a group member) #SocPharm 1/6/2010 20:44

:
@: @ smells like only copypasting replies, no conversation.. Why using Twitter if they use to talk like robots? #SocPharm 1/6/2010 20:44

:
What’s going to be the biggest change in pharma in 2010 when it comes to how they do business? Will there be a change? #socpharm 1/6/2010 20:44

:
@ : gotta disagree with you there. I don’t feel that my job is about that. I actually want to connect ppl with the best info #socpharm 1/6/2010 20:44

:
@ What I found so interesting is their “outing” a tweeter who appeared to have an AE. #socpharm 1/6/2010 20:45

:
@ : but then, I don’t have a job as a marketer, I’m just an ad hoc digital evangelist #socpharm 1/6/2010 20:45

:
@ Agreed. Heard frustrations from patients & practitioners when in the field. #SocPharm 1/6/2010 20:45

:
@ @ also isn’t following anyone. #socpharm 1/6/2010 20:46

:
“AZHelps” – I admire the effort, but feel it’s not the appropriate channel for this type of intervention. #socpharm 1/6/2010 20:46

:
@ : It’s nice to have that language, even if it is only copy/paste. You gotta start customer service somewhere #socpharm 1/6/2010 20:46

:
T2 Having trouble seeing original AZ tweet but looks like AE well handled, no? Outed how? #socpharm 1/6/2010 20:47

:
RT @: @ @ also isn’t following anyone. #socpharm <---Ouch. Hard to help if you don't listen. 1/6/2010 20:48

:
The person didn’t tweet @ but they found person talking abt Nezium & tweeted them to report AE. #socpharm 1/6/2010 20:48

:
@ : at #fdasm we talked about patients who want to be anonymous stay on anonymous sites. So, I’d say no privacy probs #socpharm 1/6/2010 20:48

:
RT @ T2 Having trouble seeing original AZ tweet, looks like AE well handled, no? Outed how? <-Agree, what's the issue? #socpharm 1/6/2010 20:48

:
Confusing how many AEs? RT @: T2 Having trouble seeing original AZ tweet but looks like AE well handled, no? Outed how? #socpharm 1/6/2010 20:49

:
@ Yeah, I don’t get that there’s a privacy issue, so I’m glad to see your comment. #socpharm 1/6/2010 20:49

:
@ Yes. I think they do truly want to help ppl with that account, but they’re like jumping into others’ conversation #SocPharm 1/6/2010 20:50

:
Last topic: We talked earlier abt #fdasm, do people feel they are stalled waiting for some guidance? #socpharm 1/6/2010 20:50

:
@ : These days you can “listen” on Twitter without “engaging”. #socpharm 1/6/2010 20:50

:
The issue is this: a person tweets to THEIR followers re: Nexium, but brand RTs to THEIR OWN followers abt PERSON on NEXIUM. Ugh. #socpharm 1/6/2010 20:50

:
I will refrain from my judgment of @. They’ve got to start somewhere. Interested to see how/if it will evolve. #socpharm #socpharm 1/6/2010 20:50

:
But if tweet something its public? RT @: The person didn’t tweet @ but they found person talking abt Nezium… #socpharm 1/6/2010 20:51

:
.@bradatpharma Seems your professional goals + pharma industry’s goals have similar means but different ends (to some degree). #SocPharm 1/6/2010 20:52

:
@ is that AZ’s promo-robot twitter account? http://twitter.com/AZhelps #socpharm 1/6/2010 20:52

:
@ : Convos are open, so they CAN jump in. They could come up with softer language but this space is about interrupting #socpharm 1/6/2010 20:52

:
@ looking at their tweet history, it looks like a punishment for the guy handling the account. always the same msg… #SocPharm 1/6/2010 20:53

:
@ I applaud AZ for this outreach. This is positive People scream if they don’t. Let’s give credit when it is due #socpharm 1/6/2010 20:53

:
OK OK enough beating up AZ…they’re trying, i guess. #socpharm 1/6/2010 20:54

:
T2 Is it a show put on for compliance officer & FDA? Maybe showing ROI of SM experiment :-) #socpharm 1/6/2010 20:54

:
RT @: Last topic: Not in our case. We are still awaing FDA approval, so all SM is disease, not brand, related #SocPharm 1/6/2010 20:54

:
Maybe @ doesn’t follow anyone because of MLR regulations about links & where they go? What if followee posted adverse f/x? #socpharm 1/6/2010 20:54

:
@ : I know @ talked about this on his PodCast. Seems like a lot of wait & see going on #socpharm 1/6/2010 20:54

:
@ damned if you do, damned if you don’t. #socpharm 1/6/2010 20:54

:
@ re AZ AE I don’t think it violates privacy since the original poster put out on Twitter for all to see #socpharm 1/6/2010 20:55

:
Methinks upcoming #FDASM guidelines could be used an opportunity to delay SM action for some pharmas #SocPharm 1/6/2010 20:55

:
Generally pple tweets knowing that it’s open to anyone and even expect anyone’s comment. Is it true for medication? I’d say yes #socpharm 1/6/2010 20:55

:
RT @ @ I applaud AZ for outreach. This is positive People scream if they don’t…give AZ credit <-Agree #socpharm 1/6/2010 20:55

:
@ Opportunity or perhaps a convenient excuse? #SocPharm 1/6/2010 20:56

:
Jason Beatty is having issues w/Nex###. I wld never have known if not 4 AZ. Do we think that’s how pharma shld hunt down AEs? #socpharm 1/6/2010 20:56

:
@ – @ should give a try to CoTweet/HootSuite to manage their account, wld help them to engage conversation #SocPharm 1/6/2010 20:56

:
Until the agendas of pharma and patients are more mutual, have more commonalities, social marketing won’t work. #socpharm 1/6/2010 20:56

:
Sorry, everybody. But sometimes I feel like we avoid the obvious. I stay employed because there’s a transaction somewhere #socpharm 1/6/2010 20:57

:
@ perceived agendas, too. #socpharm 1/6/2010 20:58

:
It doesn’t violate anything– not privacy, not HIPPA, etc… BUT, this is not all abt regs, this is also abt best practices, no? #socpharm 1/6/2010 20:58

:
@ Now that I think about it I wonder why they don’t use DMs. #socpharm 1/6/2010 20:58

:
@ Def waiting for more guidance in #fdasm, as every MLR seems to understand current regs as applied to SM differently #socpharm 1/6/2010 20:58

:
@ You got it. I think there is value in using #FDASM to elevate SM to sr mgmt to beyond what is seen as some as a fad #SocPharm 1/6/2010 20:59

:
@ and customer relations…how did that “help”. #socpharm 1/6/2010 20:59

:
@ The person would be have to following them for a DM to work. I presume that is the obstacle. #SocPharm 1/6/2010 20:59

:
@ Can’t DM someone that isn’t following you. That was my first thought too! #socpharm 1/6/2010 20:59

:
@ is great. I’m just afraid that tweeting the same msg to 100+ ppl in a conversation place might harm their credibility… #SocPharm 1/6/2010 20:59

:
Look, I’m pharmas BIGGEST fan when it comes 2 experimentation; but I still think we need 2 challenge ourselves 2 do better #socpharm 1/6/2010 21:00

:
That requires mutual following @: @ Now that I think about it I wonder why they don’t use DMs. #socpharm 1/6/2010 21:00

:
@ ah! good point, thanks #socpharm 1/6/2010 21:00

:
Thanks everyone for taking part tonight. See you Wed, January 13 at 8 pm EST for the next social media & pharma chat. #socpharm 1/6/2010 21:00

:
It seems like a lot of companies do the minimum required rather than the maximum allowed #socpharm 1/6/2010 21:01

:
@ As we know, guidance is important. Many more will cross the chasm after. Need to develop guidelines 1st. #fdasm #socpharm 1/6/2010 21:01

:
@ : thanks for facilitating, ma’am #socpharm 1/6/2010 21:02

:
@ — thank you so much for organizing this. you rock! #socpharm 1/6/2010 21:02

:
Apologies for late entry – LA traffic. I do all SM strategy for Integrated Media Solutions, a small agency with pharma clients. #socpharm 1/6/2010 21:02

:
@ 100% agree. The slow and safe route is great, but that doesn’t promote myopia. Pharma needs to step outside its bubble. #SocPharm 1/6/2010 21:02

:
@ Thanks a lot Eileen! #SocPharm 1/6/2010 21:02

:
That’s missy to you, buddy! RT @: @ : thanks for facilitating, maam #socpharm 1/6/2010 21:02

:
@ – in the hearings we discussed ways this cld be done w/more discretion – which it can. #socpharm 1/6/2010 21:02

:
Thanks for organizing! @ #socpharm 1/6/2010 21:02

:
@ This was great – thanks Eileen! #socpharm 1/6/2010 21:03

:
Their twitter acct looks like an answering machine, not really a (twitter) soul to discuss with. Average user could see it as spam #SocPharm 1/6/2010 21:03

:
@ Great chat & initiative, thank you. #socpharm 1/6/2010 21:03

:
RT @: It seems like a lot of companies do the minimum required rather than the maximum allowed #socpharm <--Exactly right. 1/6/2010 21:03

:
@ No worries, thanks for joining in. #socpharm 1/6/2010 21:03

:
My conclusion. It’s really hard to follow a Twitter discussion using teetdeck on iPhone :) … Too hard too keep up #socpharm 1/6/2010 21:03

:
@ Congrats on a good start. Moderating tweet chats is not easy. Thanks. #socpharm 1/6/2010 21:04

:
@ – Thanks to you! Good night everyone ! #SocPharm 1/6/2010 21:04

:
@ : most definitely, there’s that line that means we need to follow rules set by the agencies & behave better than expected #socpharm 1/6/2010 21:04

:
It’s time 4 change. RT @: It seems like a lot of companies do the minimum required rather than the maximum allowed #socpharm 1/6/2010 21:04

:
Tx, agree! Plan on hvng guest moderators too :)RT @: @ Congrats on good start. Moderating tweetchats is not easy #socpharm 1/6/2010 21:05

:
Q for everyone still remaining on SM monitoring: how much does it help guide potential SM strategy & tell pharma how to help pts? #socpharm 1/6/2010 21:06

:
@ Thanks so much for hosting this – it’s a great start! #socpharm 1/6/2010 21:07

:
@ I don’t see jumping as a prblm. They can just do it a lil’ bit nicer, like customizing each msg, not copypasting :-( #SocPharm 1/6/2010 21:07

:
@ It’s a critical part of SM strategy and lays the foundation. If you don’t know what’s being said, how can you engage? #SocPharm 1/6/2010 21:08

:
@ I worked w/a brand who got great insights & learned A LOT from SM monitoring. It def helped guide strategy. #socpharm 1/6/2010 21:08

:
RT @: @ : thanks for facilitating, ma’am #socpharm (yes definitely!) 1/6/2010 21:11

:
RT @: @ Thanks so much for hosting this – it’s a great start! #socpharm 1/6/2010 21:11

:
@ I think SM monitoring is a must, even if u cant join the conv the insight into the true pt perspective is invaluable #socpharm 1/6/2010 21:12

:
@ Agree. Beyond engaging tho, also helps w/all communication, what pts ask each other is what pharma should educate on #socpharm 1/6/2010 21:13

:
@ SM monitoring is like pathing the road for SM engagement (and so, strategy). It’s just mandatory (personal view) #SocPharm 1/6/2010 21:16

:
Absolutely agree. RT @: @ SM monitoring is a must, even if u cant join the conv … insight invaluable #socpharm 1/6/2010 21:16

:
#socpharm tweet chat — where was @ @ @ @ @ @ @ etc etc etc ??? 1/6/2010 21:18

:
very true RT @ what pts ask each other is what pharma should educate on #socpharm 1/6/2010 21:18

:
@ no worries. #socpharm 1/6/2010 21:18

:
@ – correction “paving the road” excuse my poor English ;-) #SocPharm 1/6/2010 21:20

:
@ “Pathing” is fine – I agree SM monitoring creates a path for all strategy by clarifying engagement tactics #socpharm 1/6/2010 21:21

:
RT @: Absolutely agree. RT @: @ SM monitoring is a must, even if u cant join the conv … insight invaluable #socpharm 1/6/2010 21:24

:
Welcome to social media & pharma. Let’s start w/ introductions. Plse say who you are & why you are interested in sm & pharma. #socpharm 1/6/2010 20:01

:
I’ll start, I work for a digital agency that focuses on pharma. I’m fascinated by sm & how it can be used 2 help pts/drs #SocPharm 1/6/2010 20:02

:
I’m Heather Powell, compliance/regulatory atty at Daiichi Sankyo. Want to help co. use SM effectively and compliantly. #socpharm #SocPharm 1/6/2010 20:02

:
@ Dana Webster – SM Specialist for ParaPRO pharma. In industry 10 yrs mostly in Diabetes sales #socpharm 1/6/2010 20:03

:
#socpharm – hello Eileen! Fabio Gratton here from Ignite Health. SM & Pharma is in my blood. Not interested. Just need it to live. :) 1/6/2010 20:03

:
Blausen Group, creator of 3D medical animation library for web & mobile- interested in patient & medical education worldwide #socpharm 1/6/2010 20:04

:
Work for @ on behalf of our Pharma clients, interested in seeing community thoughts around SM/FDA/Pharma #socpharm 1/6/2010 20:04

:
@ I’m Frieda Hernandez of Siren Interactive & cnosider that I’m part of the community #socpharm 1/6/2010 20:04

:
@ I don’t know the answer to that. I’ve only used Tweetchat.com but @ recommended twebevent. #socpharm 1/6/2010 20:04

:
@ http://tweetchat.com/room/socpharm is a good interface for hashtag chats #socpharm 1/6/2010 20:05

:
Tom Stitt, principal @, open source apps for healthcare, sometimes I moderate the #hcmktg chat, curious about #socpharm 1/6/2010 20:05

:
@ looks like twebevent is a html wrapper around tweetchat anyway #socpharm 1/6/2010 20:05

:
Kathy Mackey, Niche Marketer, watching trends in medical, pharma, & technology #SocPharm 1/6/2010 20:06

:
Tx for organizing Eileen!Chris Iafolla from SHIFT Communications. Intrigued by potential & challenges of SM for pharma #SocPharm #SocPharm 1/6/2010 20:06

:
Media Specialist @, working primarily with pharma clients. Trying to learn as much as I can. #socpharm 1/6/2010 20:07

:
I’m Maureen Miller from @, interested to see how SM bridges PR & interactive marketing. #SocPharm 1/6/2010 20:08

:
Updated www.fdasm.com so the #socpharm stream also appears now (in case you’re interested). Avail on mobile: http://m.fdasm.com/tweets.html 1/6/2010 20:09

:
Hello Eileen! Angela Dunn here. #socpharm 1/6/2010 20:09

:
Thanks for virtually coming together everyone! #socpharm 1/6/2010 20:10

:
hi all–tough day today but i’m joining the conversation for some interesting conversation and ideas tonight! #SocPharm 1/6/2010 20:10

:
I’m Erica Friedman, information professional in pharma for almost 25 years. I’d like pharma to talk to people instead of at them. #socpharm 1/6/2010 20:11

:
Don’t know if @ can make it tonight, but he’s supporting us via http://socialpharmer.com where we’ll post transcripts. #socpharm 1/6/2010 20:11

:
@ Very cool, Fabio #socpharm 1/6/2010 20:11

:
And if anybody can aggregate data well, it’s @ #socpharm 1/6/2010 20:11

:
Topic 1: What’s your biggest social media project for 2010? What aspect of social media will you be focusing on this year? #socpharm 1/6/2010 20:11

:
Update: www.fdasm.com now updated to feature #socpharm stream. Also avail on mobile devices m.fdasm.com. Follow now to hear the SM convo. 1/6/2010 20:13

:
@ I think that’s the *biggest* challenge I’ve encountered. Most marketers want to vomit value on people. #socpharm 1/6/2010 20:13

:
Nice! RT @: I’m Erica Friedman, infoprof in pharma 4 almost 25 years. I’d lk pharma 2 talk 2 ppl instead of at them. #socpharm 1/6/2010 20:14

:
@ is @ developing a #SM POV? Interested what pharma co’s are putting stake in the ground pre-FDA guidance #socpharm 1/6/2010 20:15

:
Biggest challenge? Awaiting #FDASM guidance and hoping not to mess anything up in the process #SocPharm 1/6/2010 20:15

:
@ : Creating an environment 4 mktrs 2 learn 2 curate & converse rather than broadcast is STILL a key objective 4 me #socpharm 1/6/2010 20:15

:
Biggest 2010 SM Project: Get clients 2 move forward w/SM despite anticipation & unlikely issuance of Internet/SM policies til ’11 #socpharm 1/6/2010 20:16

:
@ So we’re still in education mode w/key pharma stakeholders? #socpharm 1/6/2010 20:17

:
I am Jack healthcare digital agency strategy type guy who is still hard at work & thus will be lurking #socpharm 1/6/2010 20:17

:
Biggest challenge is developing framework and guidelines and setting appropriate expectations w/brand teams. #SocPharm 1/6/2010 20:17

:
@ @ this is hardly unique to pharma… lots of verticals dont engage with consumers and dont get why they shld #socpharm 1/6/2010 20:18

:
@ I think we started in evangelism mode and are just now moving into education mode with key stakeholders. #SocPharm 1/6/2010 20:18

:
We are exanding our medical mobile apps internationally & generating patient & medical education opportunities via social media #SocPharm 1/6/2010 20:18

:
@ : I’m hearing anecdotes and seeing behaviour that leads me to believe that corps are outsourcing the skillset #socpharm 1/6/2010 20:18

:
2010 SM Project: Harness/amplify patient voice.They are key 2 everything we do. If we are not patients today, we will be tomorrow #socpharm 1/6/2010 20:19

:
topic 1 biggest social media would have to be @ and getting that off the ground #socpharm 1/6/2010 20:19

:
Meredith Gould, zipping in somewhat late but here nevertheless. Sociologist, online strategy content development and curation. #socpharm 1/6/2010 20:19

:
we like squeaky wheels! :-) RT @: @ : I don’t get paid to do SM… I’m just a really loud, squeaky wheel. #socpharm 1/6/2010 20:19

:
Biggest SM project: educating clients and colleagues on social media, how/why to use it before they try 2 reach customers with it #socpharm 1/6/2010 20:20

:
@ True, all industries face challenges with SM, but pharma has a particularly tough row to hoe. #SocPharm 1/6/2010 20:20

:
Biggest challenge: balancing act between regulatory and actually adding value. #socpharm 1/6/2010 20:21

:
Which skills sets are we referring to (re: outsourcing)? #socpharm 1/6/2010 20:21

:
@ I think that is a concept lost on many pharma marketers. In addition to ROI, we should be talking ROH, Return on Health #SocPharm 1/6/2010 20:21

:
RT @: 2010 SM Project: Harness/amplify patient voice.They are key 2 everything we do. (True for all healthcare) #SocPharm 1/6/2010 20:21

:
@ every vertical has its unique challenges. finance has similar hurdles to pharma, for example. #socpharm 1/6/2010 20:21

:
@ : tru. but the concept of engagement just seems SO foreign 2 my marketing colleagues. like they dont grok it at ALL #socpharm 1/6/2010 20:22

:
@ definitely seeing that many co’s are outsourcing SM. Doesn’t that defy SM it by definition? Transparency, etc. #SocPharm 1/6/2010 20:23

:
@ the megaphone has been the default for years. still foreign to listen for many. #socpharm 1/6/2010 20:23

:
@ I agree there is a disconnect at times. SM is not one-way communications. #SocPharm 1/6/2010 20:23

:
@ Very true. Finance and pharma are similar in reg environment. Some don’t face that such as B2B tech for example! #SocPharm 1/6/2010 20:23

:
@ we do SM for some of our consumer clients. we’re very upfront about that fact tho. its all in how youdo it. #socpharm 1/6/2010 20:24

:
@ : and both being regulated leads to that IMHO. It feels some days, tho, that mktg doesn’t know how to talk with ppl #socpharm 1/6/2010 20:24

:
big issue : lack of desire for pharma mkters to spend the time ‘learning’ and experimenting with SM -hence need 2 outsource #socpharm 1/6/2010 20:25

:
Need 2 tape that message on our monitors, carve it on bberry, make screensaver 4 iphones, & staple 2 our head. It’s ALL abt HEALTH #socpharm 1/6/2010 20:25

:
@ Good point, change takes time. The old way of marketing/PR has been around for many years. #socpharm 1/6/2010 20:25

:
@ I don’t think it does. Pharma ultimately interacts but needs guidance, strategy, monitoring, etc…all outsourced . #SocPharm 1/6/2010 20:25

:
@ or that they think that ‘consumers’ arent ‘people’ #socpharm 1/6/2010 20:25

:
@ I think that’s great! They chose to bring someone (me) inhouse here to avoid a perceived conflict #SocPharm 1/6/2010 20:26

:
When I worked for a hospital we tracked all of our jobs via “the pathway to the patient”. How what u did impacted patients. #socpharm 1/6/2010 20:26

:
@ : I’m seeing that the skillset of “understanding what Social Media/ Networking is” is being outsourced. #socpharm 1/6/2010 20:26

:
Hi everyone! SM project for 2010: Social Media 360 monitoring, to better path the way to SM education to colleagues/stakeholders #socpharm 1/6/2010 20:26

:
@ I do agree with you in the pharma industry. My comment was intended more generally (my apologies 4 not clarifying) #SocPharm 1/6/2010 20:26

:
Technology is driving change fastr than companies can adapt 2 new expectations/behavior. Something’s got to give. #socpharm 1/6/2010 20:27

:
@ : ROI still grates on me. How does knowing that 100,000 of my ads are never seen except by bird poop a good ROI #socpharm 1/6/2010 20:27

:
Might be helpful to know that pharma isn’t the only healthcare group that has to learn a new way of communicating to users #SocPharm 1/6/2010 20:27

:
@ Don’t pharma marketers outsource everything else? #socpharm 1/6/2010 20:27

:
Outsourcing what skill sets? Strategy/creative? What companies? Agencies or pharma companies? #socpharm 1/6/2010 20:27

:
According 2 @: y is that every company thinks they have 2 have 2 talk about themselves when it comes 2 social media. #socpharm 1/6/2010 20:28

:
@ No worries! I think it is fine line to walk. Advise, counsel, monitor, are all okay. Misrepresenting is not! #SocPharm 1/6/2010 20:28

:
@ not by a long shot. #socpharm 1/6/2010 20:28

:
Glad that @ is taking part since he pointed me to the AZ AE tweet. #socpharm 1/6/2010 20:28

:
RT @ ROI grates on me. How does knowing that 100,000 of my ads are never seen except by bird poop a good ROI #socpharm /YES! 1/6/2010 20:29

:
Sorry. Knowing that I can pinpoint my target demo using Social Networking so precisely still feels like it trumps most ROI calcs. #socpharm 1/6/2010 20:29

:
@ I’m with you on ROI. Among many things, it’s a lagging indicator. #SocPharm 1/6/2010 20:29

:
T1 Biggest social media project: obliterating jargon and enhancing health literacy. #socpharm 1/6/2010 20:29

:
This is why I usually don’t get invited back to places like this… I talk too much #socpharm 1/6/2010 20:29

:
The problem with ROI is that the R has meant $ and now it means engagement leading to $. #socpharm 1/6/2010 20:30

:
Agreed RT @: Technology is driving change fastr than companies cn adapt 2 new expectations/behavior. Something’s got 2 giv. #socpharm 1/6/2010 20:30

:
yes pharma tends to outsource 2much! But SM seems even > RT @: @ Don’t pharma marketers outsource everything? #socpharm 1/6/2010 20:30

:
ROI is a marketing term, and until we move away from SM as marketing we are stuck with it. SM is relationship building. #SocPharm 1/6/2010 20:30

:
Scott Adams just wrote a great post about how humans value things we can measure over things that we can’t. #socpharm 1/6/2010 20:32

:
It still gets me we’re looking for ROI when the $ investment is … well, practically ZERO: http://tweetphoto.com/8168872 #socpharm 1/6/2010 20:32

:
personally believe our collective challenge is improving public perception about patients (not $) being top priority of pharma #SocPharm 1/6/2010 20:32

:
When people bring up ROI I just say, “easy numbers are easy, but they don’t necessarily have any value.” #socpharm 1/6/2010 20:32

:
@ : and you can’t buy a “relationship list” you’ve gotta work at it. #socpharm 1/6/2010 20:33

:
RT @: ROI is a marketing term, until we move away frm SM as marketing we r stuck with it. SM is relationship bldng. #SocPharm 1/6/2010 20:33

:
interesting disc. on ROI. On the sales side, EVERYTHING is about ROI and hitting numbers #SocPharm 1/6/2010 20:33

:
Topic 2: Look at account http://twitter.com/AZhelps for Nezium. What do u think of this? See AE tweet, does it violate privacy? #socpharm 1/6/2010 20:33

:
not sure ROI is a mktg term but a Finance one! Never heard a marketer raise it wout finance breathing downneck! RT @: #SocPharm 1/6/2010 20:33

:
@ Patient relationships still a new competency in pharma no matter what media #SocPharm 1/6/2010 20:34

:
We are so numbers focused at the beginning, but in the end we want to see HUMAN results: http://tweetphoto.com/8168952 #socpharm 1/6/2010 20:34

:
@ will defer comment on AZ as they employ my husband and pay the majority of my medical insurance #SocPharm 1/6/2010 20:34

:
I’m having fun explaining to mktrs I work with I’ve built a good following on my Twitter accounts and PodCast. Only taken 5 years #socpharm 1/6/2010 20:35

:
@ No worries! I also should’ve said that we’ll consider the comments tonight personal views and not reflecting employers. #socpharm 1/6/2010 20:36

:
! RT @: personally blv R collective challenge is improving public perception abt pts (not $) being top priority of pharma #SocPharm 1/6/2010 20:36

:
@ @ Pharma constraint itself by only looking at marketing aspects #socpharm 1/6/2010 20:37

:
RT @: I’m having fun explaining to mktrs I’ve built a good following on my Twitter and PodCast. Only taken 5 years #socpharm 1/6/2010 20:37

:
Pharma has not known the patient – they never needed to – that was not their “customer” – but things have changed. #socpharm 1/6/2010 20:38

:
Great point. RT @: @ Patient relationships still a new competency in pharma no matter what media #socpharm #socpharm 1/6/2010 20:38

:
@: re roi and new treatment. I hope roi will be before that! #socpharm 1/6/2010 20:39

:
@ Good point. Patient now plays a larger role than ever in their own health and has more information. #SocPharm 1/6/2010 20:39

:
@ do you have a link? #socpharm 1/6/2010 20:40

:
@ me too! but who knows… #socpharm 1/6/2010 20:41

:
.. and MD plays a smaller role (sadly). With pharma having a lot to lose, they need to step up. It’s not really an option. #socpharm 1/6/2010 20:41

:
Absoluyely! RT @ Patient relationships still a new competency in pharma no matter what media #SocPharm 1/6/2010 20:42

:
@ it would be great if it were just a public perception… #SocPharm 1/6/2010 20:43

:
So, no one wants to talk about http://twitter.com/AZhelps? #socpharm 1/6/2010 20:43

:
@ here’s the link http://bit.ly/8dmhBM (not sure if it is available if not a group member) #SocPharm 1/6/2010 20:44

:
@: @ smells like only copypasting replies, no conversation.. Why using Twitter if they use to talk like robots? #SocPharm 1/6/2010 20:44

:
What’s going to be the biggest change in pharma in 2010 when it comes to how they do business? Will there be a change? #socpharm 1/6/2010 20:44

:
@ : gotta disagree with you there. I don’t feel that my job is about that. I actually want to connect ppl with the best info #socpharm 1/6/2010 20:44

:
@ What I found so interesting is their “outing” a tweeter who appeared to have an AE. #socpharm 1/6/2010 20:45

:
@ : but then, I don’t have a job as a marketer, I’m just an ad hoc digital evangelist #socpharm 1/6/2010 20:45

:
@ Agreed. Heard frustrations from patients & practitioners when in the field. #SocPharm 1/6/2010 20:45

:
@ @ also isn’t following anyone. #socpharm 1/6/2010 20:46

:
“AZHelps” – I admire the effort, but feel it’s not the appropriate channel for this type of intervention. #socpharm 1/6/2010 20:46

:
@ : It’s nice to have that language, even if it is only copy/paste. You gotta start customer service somewhere #socpharm 1/6/2010 20:46

:
T2 Having trouble seeing original AZ tweet but looks like AE well handled, no? Outed how? #socpharm 1/6/2010 20:47

:
RT @: @ @ also isn’t following anyone. #socpharm <---Ouch. Hard to help if you don't listen. 1/6/2010 20:48

:
The person didn’t tweet @ but they found person talking abt Nezium & tweeted them to report AE. #socpharm 1/6/2010 20:48

:
@ : at #fdasm we talked about patients who want to be anonymous stay on anonymous sites. So, I’d say no privacy probs #socpharm 1/6/2010 20:48

:
RT @ T2 Having trouble seeing original AZ tweet, looks like AE well handled, no? Outed how? <-Agree, what's the issue? #socpharm 1/6/2010 20:48

:
Confusing how many AEs? RT @: T2 Having trouble seeing original AZ tweet but looks like AE well handled, no? Outed how? #socpharm 1/6/2010 20:49

:
@ Yeah, I don’t get that there’s a privacy issue, so I’m glad to see your comment. #socpharm 1/6/2010 20:49

:
@ Yes. I think they do truly want to help ppl with that account, but they’re like jumping into others’ conversation #SocPharm 1/6/2010 20:50

:
Last topic: We talked earlier abt #fdasm, do people feel they are stalled waiting for some guidance? #socpharm 1/6/2010 20:50

:
@ : These days you can “listen” on Twitter without “engaging”. #socpharm 1/6/2010 20:50

:
The issue is this: a person tweets to THEIR followers re: Nexium, but brand RTs to THEIR OWN followers abt PERSON on NEXIUM. Ugh. #socpharm 1/6/2010 20:50

:
I will refrain from my judgment of @. They’ve got to start somewhere. Interested to see how/if it will evolve. #socpharm #socpharm 1/6/2010 20:50

:
But if tweet something its public? RT @: The person didn’t tweet @ but they found person talking abt Nezium… #socpharm 1/6/2010 20:51

:
.@bradatpharma Seems your professional goals + pharma industry’s goals have similar means but different ends (to some degree). #SocPharm 1/6/2010 20:52

:
@ is that AZ’s promo-robot twitter account? http://twitter.com/AZhelps #socpharm 1/6/2010 20:52

:
@ : Convos are open, so they CAN jump in. They could come up with softer language but this space is about interrupting #socpharm 1/6/2010 20:52

:
@ looking at their tweet history, it looks like a punishment for the guy handling the account. always the same msg… #SocPharm 1/6/2010 20:53

:
@ I applaud AZ for this outreach. This is positive People scream if they don’t. Let’s give credit when it is due #socpharm 1/6/2010 20:53

:
OK OK enough beating up AZ…they’re trying, i guess. #socpharm 1/6/2010 20:54

:
T2 Is it a show put on for compliance officer & FDA? Maybe showing ROI of SM experiment :-) #socpharm 1/6/2010 20:54

:
RT @: Last topic: Not in our case. We are still awaing FDA approval, so all SM is disease, not brand, related #SocPharm 1/6/2010 20:54

:
Maybe @ doesn’t follow anyone because of MLR regulations about links & where they go? What if followee posted adverse f/x? #socpharm 1/6/2010 20:54

:
@ : I know @ talked about this on his PodCast. Seems like a lot of wait & see going on #socpharm 1/6/2010 20:54

:
@ damned if you do, damned if you don’t. #socpharm 1/6/2010 20:54

:
@ re AZ AE I don’t think it violates privacy since the original poster put out on Twitter for all to see #socpharm 1/6/2010 20:55

:
Methinks upcoming #FDASM guidelines could be used an opportunity to delay SM action for some pharmas #SocPharm 1/6/2010 20:55

:
Generally pple tweets knowing that it’s open to anyone and even expect anyone’s comment. Is it true for medication? I’d say yes #socpharm 1/6/2010 20:55

:
RT @ @ I applaud AZ for outreach. This is positive People scream if they don’t…give AZ credit <-Agree #socpharm 1/6/2010 20:55

:
@ Opportunity or perhaps a convenient excuse? #SocPharm 1/6/2010 20:56

:
Jason Beatty is having issues w/Nex###. I wld never have known if not 4 AZ. Do we think that’s how pharma shld hunt down AEs? #socpharm 1/6/2010 20:56

:
@ – @ should give a try to CoTweet/HootSuite to manage their account, wld help them to engage conversation #SocPharm 1/6/2010 20:56

:
Until the agendas of pharma and patients are more mutual, have more commonalities, social marketing won’t work. #socpharm 1/6/2010 20:56

:
Sorry, everybody. But sometimes I feel like we avoid the obvious. I stay employed because there’s a transaction somewhere #socpharm 1/6/2010 20:57

:
@ perceived agendas, too. #socpharm 1/6/2010 20:58

:
It doesn’t violate anything– not privacy, not HIPPA, etc… BUT, this is not all abt regs, this is also abt best practices, no? #socpharm 1/6/2010 20:58

:
@ Now that I think about it I wonder why they don’t use DMs. #socpharm 1/6/2010 20:58

:
@ Def waiting for more guidance in #fdasm, as every MLR seems to understand current regs as applied to SM differently #socpharm 1/6/2010 20:58

:
@ You got it. I think there is value in using #FDASM to elevate SM to sr mgmt to beyond what is seen as some as a fad #SocPharm 1/6/2010 20:59

:
@ and customer relations…how did that “help”. #socpharm 1/6/2010 20:59

:
@ The person would be have to following them for a DM to work. I presume that is the obstacle. #SocPharm 1/6/2010 20:59

:
@ Can’t DM someone that isn’t following you. That was my first thought too! #socpharm 1/6/2010 20:59

:
@ is great. I’m just afraid that tweeting the same msg to 100+ ppl in a conversation place might harm their credibility… #SocPharm 1/6/2010 20:59

:
Look, I’m pharmas BIGGEST fan when it comes 2 experimentation; but I still think we need 2 challenge ourselves 2 do better #socpharm 1/6/2010 21:00

:
That requires mutual following @: @ Now that I think about it I wonder why they don’t use DMs. #socpharm 1/6/2010 21:00

:
@ ah! good point, thanks #socpharm 1/6/2010 21:00

:
Thanks everyone for taking part tonight. See you Wed, January 13 at 8 pm EST for the next social media & pharma chat. #socpharm 1/6/2010 21:00

:
It seems like a lot of companies do the minimum required rather than the maximum allowed #socpharm 1/6/2010 21:01

:
@ As we know, guidance is important. Many more will cross the chasm after. Need to develop guidelines 1st. #fdasm #socpharm 1/6/2010 21:01

:
@ : thanks for facilitating, ma’am #socpharm 1/6/2010 21:02

:
@ — thank you so much for organizing this. you rock! #socpharm 1/6/2010 21:02

:
Apologies for late entry – LA traffic. I do all SM strategy for Integrated Media Solutions, a small agency with pharma clients. #socpharm 1/6/2010 21:02

:
@ 100% agree. The slow and safe route is great, but that doesn’t promote myopia. Pharma needs to step outside its bubble. #SocPharm 1/6/2010 21:02

:
@ Thanks a lot Eileen! #SocPharm 1/6/2010 21:02

:
That’s missy to you, buddy! RT @: @ : thanks for facilitating, maam #socpharm 1/6/2010 21:02

:
@ – in the hearings we discussed ways this cld be done w/more discretion – which it can. #socpharm 1/6/2010 21:02

:
Thanks for organizing! @ #socpharm 1/6/2010 21:02

:
@ This was great – thanks Eileen! #socpharm 1/6/2010 21:03

:
Their twitter acct looks like an answering machine, not really a (twitter) soul to discuss with. Average user could see it as spam #SocPharm 1/6/2010 21:03

:
@ Great chat & initiative, thank you. #socpharm 1/6/2010 21:03

:
RT @: It seems like a lot of companies do the minimum required rather than the maximum allowed #socpharm <--Exactly right. 1/6/2010 21:03

:
@ No worries, thanks for joining in. #socpharm 1/6/2010 21:03

:
My conclusion. It’s really hard to follow a Twitter discussion using teetdeck on iPhone :) … Too hard too keep up #socpharm 1/6/2010 21:03

:
@ Congrats on a good start. Moderating tweet chats is not easy. Thanks. #socpharm 1/6/2010 21:04

:
@ – Thanks to you! Good night everyone ! #SocPharm 1/6/2010 21:04

:
@ : most definitely, there’s that line that means we need to follow rules set by the agencies & behave better than expected #socpharm 1/6/2010 21:04

:
It’s time 4 change. RT @: It seems like a lot of companies do the minimum required rather than the maximum allowed #socpharm 1/6/2010 21:04

:
Tx, agree! Plan on hvng guest moderators too :)RT @: @ Congrats on good start. Moderating tweetchats is not easy #socpharm 1/6/2010 21:05

:
Q for everyone still remaining on SM monitoring: how much does it help guide potential SM strategy & tell pharma how to help pts? #socpharm 1/6/2010 21:06

:
@ Thanks so much for hosting this – it’s a great start! #socpharm 1/6/2010 21:07

:
@ I don’t see jumping as a prblm. They can just do it a lil’ bit nicer, like customizing each msg, not copypasting :-( #SocPharm 1/6/2010 21:07

:
@ It’s a critical part of SM strategy and lays the foundation. If you don’t know what’s being said, how can you engage? #SocPharm 1/6/2010 21:08

:
@ I worked w/a brand who got great insights & learned A LOT from SM monitoring. It def helped guide strategy. #socpharm 1/6/2010 21:08

:
RT @: @ : thanks for facilitating, ma’am #socpharm (yes definitely!) 1/6/2010 21:11

:
RT @: @ Thanks so much for hosting this – it’s a great start! #socpharm 1/6/2010 21:11

:
@ I think SM monitoring is a must, even if u cant join the conv the insight into the true pt perspective is invaluable #socpharm 1/6/2010 21:12

:
@ Agree. Beyond engaging tho, also helps w/all communication, what pts ask each other is what pharma should educate on #socpharm 1/6/2010 21:13

:
@ SM monitoring is like pathing the road for SM engagement (and so, strategy). It’s just mandatory (personal view) #SocPharm 1/6/2010 21:16

:
Absolutely agree. RT @: @ SM monitoring is a must, even if u cant join the conv … insight invaluable #socpharm 1/6/2010 21:16

:
#socpharm tweet chat — where was @ @ @ @ @ @ @ etc etc etc ??? 1/6/2010 21:18

:
very true RT @ what pts ask each other is what pharma should educate on #socpharm 1/6/2010 21:18

:
@ no worries. #socpharm 1/6/2010 21:18

:
@ – correction “paving the road” excuse my poor English ;-) #SocPharm 1/6/2010 21:20

:
@ “Pathing” is fine – I agree SM monitoring creates a path for all strategy by clarifying engagement tactics #socpharm 1/6/2010 21:21

:
RT @: Absolutely agree. RT @: @ SM monitoring is a must, even if u cant join the conv … insight invaluable #socpharm 1/6/2010 21:24

About Eileen O'Brien

Eileen has more than 16 years of digital healthcare marketing experience. She is an opinion leader on social media and biopharma, and has been invited to speak at industry conferences and quoted in publications.

View other posts from Eileen

Siren Interactive
  • Siren Interactive
  • Rare Disease Relationship Marketing Experts
  • 626 West Jackson Blvd, Suite 100
  • Chicago, IL 60661
  • 312.204.6700
  • 866.502.6714 (Toll Free)
  • www.sireninteractive.com